Talk:Valganciclovir: Difference between revisions
| Line 14: | Line 14: | ||
(Glori Wai, Brandon Salce, Sarita Wanichpan, Stephanie Roman) |
(Glori Wai, Brandon Salce, Sarita Wanichpan, Stephanie Roman) |
||
PEER REVIEW FROM GROUP 30: |
|||
STUDENT 1 – Does the draft submission reflect a neutral point of view? If not, specify… |
STUDENT 1 – Does the draft submission reflect a neutral point of view? If not, specify… |
||
: I believe most of the statements themselves are written neutrally, but question the neutrality of the Research section in that it is quoting only one trial's results about a controversial syndrome in itself (chronic fatigue). Although not the focus of my class assignment question, I will also point out the pharmacokinetics are all already available in the right-hand side's chembox so I'm not sure if it should be an article section. [[User:Stevenwsamuels|Stevenwsamuels]] ([[User talk:Stevenwsamuels|talk]]) 08:11, 15 November 2016 (UTC) |
: I believe most of the statements themselves are written neutrally, but question the neutrality of the Research section in that it is quoting only one trial's results about a controversial syndrome in itself (chronic fatigue). Although not the focus of my class assignment question, I will also point out the pharmacokinetics are all already available in the right-hand side's chembox so I'm not sure if it should be an article section. [[User:Stevenwsamuels|Stevenwsamuels]] ([[User talk:Stevenwsamuels|talk]]) 08:11, 15 November 2016 (UTC) |
||
Revision as of 19:48, 15 November 2016
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Valganciclovir.
|
{{WikiProject banner shell}} to this page and add the quality rating to that template instead of this project banner. See WP:PIQA for details. | Pharmacology Start‑class Mid‑importance | |||||||||
| ||||||||||
This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Bsalce, Swani8, Gloring14, Stephanie.eg (article contribs). Peer reviewers: Jborbon, Iaminwillmart, Rahatm786, Ktham.
Group 29 Edit Plan
1. Mechanism of Action 2. Toxicity 3. Drug Interaction 4. Clinical Use
We will use PubMed to update this section.
(Glori Wai, Brandon Salce, Sarita Wanichpan, Stephanie Roman)
PEER REVIEW FROM GROUP 30: STUDENT 1 – Does the draft submission reflect a neutral point of view? If not, specify…
- I believe most of the statements themselves are written neutrally, but question the neutrality of the Research section in that it is quoting only one trial's results about a controversial syndrome in itself (chronic fatigue). Although not the focus of my class assignment question, I will also point out the pharmacokinetics are all already available in the right-hand side's chembox so I'm not sure if it should be an article section. Stevenwsamuels (talk) 08:11, 15 November 2016 (UTC)
STUDENT 2 – Are the points included verifiable with cited secondary sources that are freely accessible? If not, specify…
STUDENT 3 – Are the edits formatted consistent with Wikipedia’s manual of style for medicine-related articles? If not, specify…
STUDENT 4 – Is there any evidence of plagiarism or copyright violation? If yes, specify…
- The majority of the article looks free from plagiarism or copyright violation. One area I would be sure to include citations for is the pharmacokinetics section. One more edit I think would be beneficial is to change the wording (in the last paragraph of the Research section from "In a free preview of ....." to something with the title of the article in it "Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease" Iaminwillmart (talk) 18:09, 15 November 2016 (UTC)